Related and Nonrelated Parties [Axis]
Nonrelated Party [Member]
Related Party [Member]
Product and Service [Axis]
Commission Income [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Medical [Member]
Timing of Transfer of Good or Service [Axis]
Regular [Member]
Life [Member]
Property and Casualty [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Legal Entity [Axis]
Priority Health [Member]
BlueCross BlueShield [Member]
Investment, Name [Axis]
Enquantum Ltd [Member]
Innervate [Member]
Debt Instrument [Axis]
Bridge Loan [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Share Purchase Agreement [Member]
LifeSci Global Group LLC [Member]
Life Sci Management Group LLC [Member]
LGG Note [Member]
Innervate Radiopharmaceuticals LLC [Member]
Subscription Agreement [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Intangible Asset, Finite-Lived, Class [Axis]
Trademarks and Trade Names [Member]
Internally Developed Software [Member]
Customer Relationships [Member]
Noncompete Agreements [Member]
Crypto Asset [Axis]
ZEC [Member]
Credit Facility [Axis]
Barra [Member]
ATM Agreement [Member]
Pompensation Programs [Member]
Short-Term Debt, Type [Axis]
Line of Credit [Member]
Title and Position [Axis]
Executive Officer [Member]
Employment Agreement [Member]
Plan Name [Axis]
Equity Incentive Plan [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
2025 Equity Incentive Plan [Member]
Award Type [Axis]
At The Market Offering Program [Member]
Prefunded Warrants [Member]
Warrant [Member]
Sale of Stock [Axis]
Private Placement [Member]
Purchase Agreement [Member]
Antidilutive Securities [Axis]
Series A Warrants [Member]
PAW [Member]
PA Warrants [Member]
Series J Warrants [Member]
Series J PAW [Member]
Series K Warrants [Member]
Series K PAW [Member]
Unvested Stock Awards [Member]
Revolving Credit Facility [Member]
Credit Agreement [Member]
Settlement Agreement [Member]
Segments [Axis]
Insurance [Member]
Subsegments [Axis]
Total Insurance Segment Revenue [Member]
Total Segments [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
Assets
Current assets:
Cash
Restricted cash
Accounts receivable
Other receivables
Prepaid expense and other current assets
Total current assets
Property and equipment, net
Right-of-use assets
Equity Investments
Intangibles, net
Goodwill
Digital assets, fair value
Other non-current assets
Total assets
Liabilities and Equity
Current liabilities:
Accounts payable and other accrued liabilities
Short-term financing agreements
Current portion of loans payables, related parties
Other payables
Current portion of long-term debt
Operating lease liability, current portion
Total current liabilities
Long term debt, less current portion
Operating lease liability, less current portion
Total liabilities
Stockholders’ equity:
Preferred stock, $0.086 par value; 750,000,000 shares authorized and 0 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common stock, $0.086 par value; 50,000,000 shares authorized and 820,948 and 266,103 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total Reliance Global Group, Inc. stockholders’ equity
Noncontrolling interest
Total stockholders’ equity
Total liabilities and stockholders’ equity
Statement of Financial Position [Abstract]
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Statement [Table]
Statement [Line Items]
Revenue:
Commission income
Total revenue
Operating expenses:
Commission expense
Salaries and wages
General and administrative expenses
Marketing and advertising expenses
Depreciation and amortization
Total operating expenses
Loss from operations
Other income (expense):
Interest expense
Other income (expense), net
Loss from equity method investment
Realized and unrealized gains on digital assets, net
Total other (expense) income
Net loss
Less: Net loss attributable to noncontrolling interests
Net loss attributable to Reliance Global Group, Inc.
Basic loss per share
Diluted loss per share
Weighted average number of shares outstanding-basic
Weighted average number of shares outstanding-diluted
Balance
Balance, shares
Common share-based compensation
Common share-based compensation, shares
Common shares issued for ATM share sales
Common shares issued for ATM share sales, shares
Common shares and warrants issued for a public offering
Common shares and warrants issued for a public offering, shares
Deemed dividend
Net loss
Additional public offering costs
Common shares issued for reverse stock split round up
Common shares issued for reverse stock split round up, shares
Common shares issued for services
Common shares issued for services, shares
Common shares issued pursuant to sales on an Equity Line of Credit
Common shares issued pursuant to sales on an Equity Line of Credit, shares
Common shares issued for acquisition purchase price prepayment
Common stock issued for acquisition purchase price prepayment, shares
Common shares issued for private placement
Common shares issued for private placement, shares
Balance
Balance, shares
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Adjustment to reconcile net income to net cash used in operating activities:
Depreciation and amortization
Amortization of debt issuance costs and accretion of debt discount
Non-cash lease expense
Equity based compensation expense
Equity based payments to third parties
Loss on equity method investment
Realized gain on digital assets, net
Change in operating assets and liabilities:
Accounts receivable
Accounts receivable, related parties
Other receivables
Prepaid expense and other current assets
Accounts payables and other accrued liabilities
Other payables
Net cash used in continuing operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment
Purchase of intangibles
Sale of digital assets
Investments in equity investments
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal repayments of debt
Proceeds from short term financings
Principal repayments of short term financings
Proceeds from loans payable, related parties
Payments of loans payable, related parties
Series J Private Placement
Proceeds from common shares issued through an at the market offering
Proceeds from common shares issued through a public offering
Proceeds from common shares issued through an Equity Line of Credit
Cash paid for deemed dividends
Net cash provided by continuing financing activities
Net (decrease) increase in cash and restricted cash
Cash and restricted cash at beginning of period
Cash and restricted cash at end of period
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Accounting Policies [Abstract]
SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES
Equity Method Investments and Joint Ventures [Abstract]
Equity Investments
Intangible Asset, Goodwill and Other [Abstract]
INTANGIBLE ASSETS
DIGITAL ASSETS
Debt Disclosure [Abstract]
LONG-TERM DEBT AND SHORT-TERM FINANCINGS
Equity [Abstract]
EQUITY
Earnings Per Share [Abstract]
EARNINGS (LOSS) PER SHARE
Leases
LEASES
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Segment Reporting [Abstract]
SEGMENT REPORTING
Basis of Presentation and Principles of Consolidation
Liquidity
Use of Estimates
Cash and Restricted Cash
Equity Investments
Equity Method Investments
Revenue Recognition
Income Taxes
Noncontrolling Interests
Recently Issued Accounting Pronouncements
SCHEDULE OF CASH AND RESTRICTED CASH IN STATEMENTS OF CASH FLOW
SCHEDULE OF DISAGGREGATION REVENUE
SCHEDULE OF CONCENTRATIONS OF REVENUES
SCHEDULE OF EQUITY INVESTMENTS
SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD
SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS
SCHEDULE OF DIGITAL ASSETS
SCHEDULE OF LONG TERM DEBT
SCHEDULE OF CUMULATIVE MATURITIES OF LONG -TERM LOANS AND CREDIT FACILITIES
SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS
SCHEDULE OF DILUTIVE NET LOSS PER COMMON SHARE
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT
SCHEDULE OF FINANCIAL OF INFORMATION FOR REPORTABLE SEGMENT
Total cash and restricted cash
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Revenue
Concentration of risk percentage
Cash and restricted cash
Current assets
Current liabilities
Working capital
Stockholder's equity
Loss from operations
Net loss
Income tax expenses
Equity Method Investment [Table]
Schedule of Equity Method Investments [Line Items]
Ownership percentage
Total equity investments, carrying value
Secured bridge loan
Aggregate consideration
Investment amount funded
Number of shares acquired
Percentage of issued and outstanding shares
Unfunded portion of investment
Carrying value of investment
Equity method losses
Purchase price exceeded share and underlying net assets
Note advances maximum amount
Bearing interest percentage
Maturity date
Face amount
Amount funded for acquisition
Number of units held
Warrants held
Warrants exercise price
Warrants acquired
Intangible Asset, Finite-Lived [Table]
Intangible Asset, Finite-Lived [Line Items]
Weighted Average Remaining Amortization Period (Years)
Gross Carrying Amount
Accumulated Amortization
Net Carrying Amount
2026
2027
2028
2029
2030
Thereafter
Total
Crypto Asset, Holding [Table]
Crypto Asset, Holding [Line Items]
Holdings
Cost basis
Fair value
Line of Credit Facility [Table]
Line of Credit Facility [Line Items]
Oak Street Funding LLC Term Loan for the acquisition of Barra & Associates, LLC, variable interest of prime rate plus 2.5%, maturing May 2032, net of deferred financing costs of $123,198 and $133,909 as of June 30, 2026, and December 31, 2025, respectively
Less: current portion
Long-term debt
Variable interest of prime rate plus
Maturity date
Net of deferred financing cost
2026
2027
2028
2029
2030
Thereafter
Total
Less: debt issuance costs
Total
Interest rate
Short term financing agreements
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reverse stock split
Shares issued due to a reverse split, shares
Equity based compensation shares
Equity based compensation shares value
Public offering of common shares
Public offering of common shares value
Shares issued
Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture
Number of shares issued for services
Value of shares issued for services
Number of shares issued
Value of shares issued
Additional public offering costs
Number of shares awarded
Vesting period
Number of shares vesting each year
Number of shares vesting fair value
Unrecognized compensation cos
Compensation expense
Stock-based compensation expense
Shares granted
Compensation commitee amount
Number of shares available for issuance
Sale of stock, number of shares issued in transaction
Number of shares net proceeds
Share price
Warrant exercise price
Gross proceeds
Number of shares exercised
Gross proceeds
Warrants outstanding
Line of credit facility, commitment fee amount
Proceeds from lines of credit
Line of credit facility, remaining borrowing capacity
Net loss attributable to Reliance Global Group, Inc.
Less: deemed dividend adjustment
Net loss, numerator, basic computation
Net loss, numerator, dilutive computation
Weighted average common shares, basic
Weighted average common shares, dilutive
Loss per common share – basic
Loss per common share – diluted
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares subject to outstanding
Schedule Of Future Minimum Lease Payment
2026
2027
2028
2029
2030
Thereafter
Total undiscounted operating lease payments
Less: Imputed interest
Present value of operating lease liabilities
Lease expense
Weighted average remaining lease term
Weighted average discount rate
Legal contingencies
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Credit facility
Related party receivable
Loans payable
Interest expense
Aggregate cash consideration
Segment Reporting [Table]
Segment Reporting [Line Items]
Total segment revenue
Marketing and advertising
Interest expense
Total segment net income (loss)
Total insurance segment net income
Corporate overhead
Depreciation and amortization
Number of Reportable Segments
Commission income.
Commission expense.
Stock issued during period value for reverse stock split round up.
Stock issued during period value for private placement.
Liquidity Policy [Text Block]
Equity Investments [Policy]
Medical [Member]
Regular [Member]
Life [Member]
Property and Casualty [Member]
Priority Health [Member]
BlueCross BlueShield [Member]
Non Controlling Interest [Policy Text Block]
Innervate [Member]
Enquantum Ltd [Member]
Share Purchase Agreement [Member]
Life Sci Management Group LLC [Member]
Innervate Radiopharmaceuticals LLC [Member]
Subscription Agreement [Member]
Internally Developed Software [Member]
Finite lived intangible assets amortization expense after year four.
Warrants acquired.
Crypto assets number of units.
ZEC [Member]
Barra [Member]
Long term debt maturities repayments of principal after year four.
ATM Agreement [Member]
Employment Agreement [Member]
At The Market Offering Program [Member]
Equity Incentive Plan [Member]
Prefunded Warrants [Member]
Purchase Agreement [Member]
Deemed dividend adjustment.
Series A Warrants [Member]
PAW [Member]
PA Warrants [Member]
Thereafter.
Credit Agreement [Member]
Aggregate cash consideration.
Settlement Agreement [Member]
Total Segments [Member]
General and administrative expenses
Marketing and advertising expenses.
Proceeds from common shares issued through equity line of credit.
Pompensation Programs [Member]
Insurance [Member]
Strategic Ventures [Member]
Unvested Stock Awards [Member]
Stock issued during period shares for private placement.
Stock issued during period value common stock and warrants for public offering.
Stock issued during period shares common stock and warrants for public offering.
2025 Equity Incentive Plan [Member]
Working capital deficiency.
Grant salary insurance segment expense.
Commission Income [Member]
LifeSci Global Group LLC [Member]
LGG Note [Member]
Series K PAW [Member]
Series K Warrants [Member]
Series J PAW [Member]
Series J Warrants [Member]
Segment net income loss.
Total Insurance Segment Revenue [Member]
Total insurance segment net income
Assets [Default Label]
Liabilities
Equity, Attributable to Parent
Liabilities and Equity [Default Label]
Operating Expenses
Operating Income (Loss)
Interest Expense, Nonoperating
Nonoperating Income (Expense)
Shares, Outstanding
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings
Depreciation, Depletion and Amortization
Other Noncash Income (Expense)
Crypto Asset, Realized Gain, Nonoperating
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Accounts Receivable, Related Parties
Increase (Decrease) in Other Receivables
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Other Accounts Payable
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Intangible Assets
Payments to Acquire Equity Securities, FV-NI
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Repayments of Debt
Repayments of Short-Term Debt
Payments of Dividends
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Equity Method Investments and Joint Ventures Disclosure [Text Block]
EquityInvestmentsPolicy
Working capital deficiency
Debt Instrument, Maturity Date, Description
Long-Term Debt, Maturity, Remainder of Fiscal Year
Long-Term Debt, Maturity, Year One
Long-Term Debt, Maturity, Year Two
Long-Term Debt, Maturity, Year Three
Long-Term Debt, Maturity, Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
Long-Term Debt, Gross
Debt Issuance Costs, Net
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Lessee, Operating Lease, Liability, to be Paid, Year One
Lessee, Operating Lease, Liability, to be Paid, Year Two
Lessee, Operating Lease, Liability, to be Paid, Year Three
Lessee, Operating Lease, Liability, to be Paid, Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
GrantSalaryInsuranceSegmentExpense